Angiogenesis as a biomarker and target in cancer chemoprevention

The Lancet Oncology
R A SharmaK J O'Byrne

Abstract

Angiogenesis, the formation of new blood vessels from existing vasculature, is essential to the late stages of carcinogenesis, allowing tumours to grow beyond 1-2 mm in diameter, invade surrounding tissue, and metastasise. However, more than two decades ago, angiogenesis that preceded neoplastic transformation was seen. Indeed, it can be detected in inflammatory and infectious diseases that increase the risk of developing cancer. Recent advances in fluorescence endoscopy and histological assessment suggest that, for certain cancers, the degree of new blood-vessel formation may differ between the early and late stages of carcinogenic progression. The association between angiogenesis and cancer occurrence, and ease of detection of this process in accessible tissues early in carcinogenesis, mean that angiogenesis fulfils the criteria for a biomarker of the effectiveness of chemopreventive intervention. There is also some evidence that biochemical assays of angiogenic growth factors may offer similar potential as surrogate biomarkers. Many natural and synthetic chemopreventive agents in development or in clinical use inhibit new vessel formation in vivo. Validation of angiogenesis as a biomarker for the effectiveness of chemopreven...Continue Reading

References

Oct 1, 1977·Nature·P J PolveriniE R Unanue
May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·A AlbiniB Ensoli
Aug 15, 1994·Annals of Internal Medicine·E GiovannucciW C Willett
Apr 1, 1996·The Journal of Pathology·H Bielefeldt-OhmannD R Fitzpatrick
Aug 1, 1996·The Journal of Clinical Investigation·O V VolpertN P Bouck
Dec 1, 1995·Cancer Metastasis Reviews·J RakR S Kerbel
Oct 1, 1996·Virchows Archiv : an International Journal of Pathology·A Fisseler-EckhoffK M Müller
May 2, 1997·International Journal of Cancer. Journal International Du Cancer·D J Lindner, E C Borden
Aug 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G FontaniniG Bevilacqua
Jan 12, 1999·American Journal of Epidemiology·S T MayneD T Janerich
Apr 14, 1999·Nature·Y Cao, R Cao
Jun 22, 1999·Oncology Reports·G FontaniniF Basolo
Feb 19, 2000·Biochemical and Biophysical Research Communications·S W LeeK W Kim
Feb 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·A PozziH A Gardner
Mar 31, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K J O'ByrneA L Harris
Mar 31, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N SekiT Kudo
Aug 10, 2000·Neoplasia : an International Journal for Oncology Research·D SmedleyN C Cross
Nov 22, 2000·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Y HosomiA Ochiai
Mar 22, 2002·The Lancet Oncology·A J GescherW P Steward

❮ Previous
Next ❯

Citations

Jan 23, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Zhaofei LiuXiaoyuan Chen
Jun 15, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Clarissa Gerhäuser
Dec 25, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·C M RichardsonKenneth J O'Byrne
Mar 29, 2008·Antioxidants & Redox Signaling·Alexios S Strimpakos, Ricky A Sharma
Aug 13, 2011·Applied Immunohistochemistry & Molecular Morphology : AIMM·Jacqueline S NicolosiAndré Almeida Schenka
Nov 29, 2002·Molecular Pathology : MP·E S Bamberger, C W Perrett
May 7, 2011·Theranostics·Zhaofei LiuXiaoyuan Chen
Mar 13, 2016·Seminars in Oncology·Bríd M Ryan, Jessica M Faupel-Badger
Jul 6, 2010·Biochemical and Biophysical Research Communications·Chuan-Xiu BianBing-Hua Jiang
Jan 1, 2008·Drug Development Research·Zhaofei LiuXiaoyuan Chen
Sep 18, 2008·International Journal of Cancer. Journal International Du Cancer·Gagan DeepRajesh Agarwal
Nov 30, 2011·Molecular Nutrition & Food Research·Sharon C ReubenAnupam Bishayee
Aug 6, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R A SharmaW P Steward
Jun 21, 2005·International Journal of Radiation Oncology, Biology, Physics·Xian LuoDaila S Gridley
Jan 1, 2016·Molecular Nutrition & Food Research·Dushani L PalliyaguruThomas W Kensler
Jan 1, 2011·Cancers·Zhenjian CaiWilliam N Rom
Jun 1, 2004·Laboratory Investigation; a Journal of Technical Methods and Pathology·Sue C HeffelfingerDavid Warshawsky
Nov 1, 2002·The International Journal of Biological Markers·A ParadisoUNKNOWN Italian Network for Quality Assessment of Tumor Biomarkers
Mar 3, 2018·Frontiers in Cell and Developmental Biology·Rafiq A Rather, Madhulika Bhagat
Jul 6, 2019·Molecular Biology Reports·Mariia ZadorozhnaDomenica Mangieri
Dec 5, 2013·International Journal of Cancer. Journal International Du Cancer·Aline H GuarientoFernando S Moreno
Dec 14, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Miguel López-Lázaro
Nov 6, 2020·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Christian Rafael QuijiaMarlus Chorilli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Related Papers

Nature Reviews. Cancer
Gabriele Bergers, Laura E Benjamin
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Francesca TosettiAdriana Albini
Current Opinion in Clinical Nutrition and Metabolic Care
Virginie GranciClaude Pichard
© 2022 Meta ULC. All rights reserved